Controlled release delivery system for nasal application of...

Details Controlled release delivery system for nasal application of... Controlled release delivery system for nasal application of...

A - Human Necessities

61

K

A61K 9/00 (2006.01) A61K 9/06 (2006.01) A61K 31/00 (2006.01)

Patent

CA 2664427

This invention relates to a galenical gel formulation for nasal administration of neurotransmitters such as dopamine. The special lipophilic or partly lipophilic system of the invention leads to high bioavailability of the active ingredient in plasma and brain caused by sustained serum levels and/or direct or partly direct transport from nose to the brain.

Cette invention concerne une formulation de gel galénique pour administration nasale de neurotransmetteurs tels que la dopamine. Le système spécial lipophile ou partiellement lipophile de l'invention conduit à une biodisponibilité élevée de l'ingrédient actif dans le plasma et le cerveau provoquée par des taux de sérum entretenus et/ou un transport direct ou partiellement direct du nez au cerveau.

Affiliated with

Also associated with

Rating

Controlled release delivery system for nasal application of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release delivery system for nasal application of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release delivery system for nasal application of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1435025